Mehmet Turan Basunlu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mehmet Turan Basunlu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Emre Oteyaka
Istanbul Medipol University
3 shared publications - Gizem Sari
Istanbul Medipol University
3 shared publications - Halil Türkoğlu
Istanbul Medipol Universitesi, Turkey
3 shared publications - Murat Ugurlucan
Liv Hospital, Division of Cardiovascular Surgery, Istanbul, Turkey
3 shared publications - Okan Eren Kuguoglu
ISTANBUL MEDIPOL UNIVERSITY, INTERNATIONAL FACULTY OF MEDICINE
3 shared publications - Yilmaz Yozgat
Radiology, Maltepe University, Istanbul, Türkiye
2 shared publications
Latest Publications
- 26 February 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (2) , 258-261
Role of midodrine in children with recurrent vasovagal syncope: a retrospective examination of therapeutic outcomes
Background: Vasovagal syncope is the most common cause of syncope in children, and there is no satisfactory treatment currently. We evaluated the response to midodrine treatment in patients with vasovagal syncope who failed to benefit from conventional, non-pharmacologic treatments. Materials and methods: The study was a single-centre retrospective study. The data of 44 children between the ages of 6 and 18 years, who were diagnosed with recurrent vasovagal syncope, did not benefit from non- pharmacological treatments, and received midodrine treatment from 2015 to 2022 were enrolled in the study. Results: In total, 44 patients, 38 (86.4%) were girls, and 6 (13.6%) were boys. The primary outcome measure was the change in frequency of vasovagal syncope episodes from baseline to 6 months after treatment with midodrine. Patients received a midodrine treatment at an average of 2.5–5 mg/day and were followed for a median of 23.07 (8–72) months. The median number of syncope was 4.2 (3–9.8)/year prior to treatment and 1.2 (1–5)/year ( p = 0.01) following the treatment. There was a significant improvement in syncope episodes in all patients. Conclusion: Vasovagal syncope is the common cause of syncope in children, and its treatment has not yet been found satisfactory. Midodrine treatment was found to be effective and safe in paediatric patients with recurrent vasovagal syncope. However, further research is needed to determine the most effective treatment for this condition.
- 26 February 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (2) , 258-261
Role of midodrine in children with recurrent vasovagal syncope: a retrospective examination of therapeutic outcomes
Background: Vasovagal syncope is the most common cause of syncope in children, and there is no satisfactory treatment currently. We evaluated the response to midodrine treatment in patients with vasovagal syncope who failed to benefit from conventional, non-pharmacologic treatments. Materials and methods: The study was a single-centre retrospective study. The data of 44 children between the ages of 6 and 18 years, who were diagnosed with recurrent vasovagal syncope, did not benefit from non- pharmacological treatments, and received midodrine treatment from 2015 to 2022 were enrolled in the study. Results: In total, 44 patients, 38 (86.4%) were girls, and 6 (13.6%) were boys. The primary outcome measure was the change in frequency of vasovagal syncope episodes from baseline to 6 months after treatment with midodrine. Patients received a midodrine treatment at an average of 2.5–5 mg/day and were followed for a median of 23.07 (8–72) months. The median number of syncope was 4.2 (3–9.8)/year prior to treatment and 1.2 (1–5)/year ( p = 0.01) following the treatment. There was a significant improvement in syncope episodes in all patients. Conclusion: Vasovagal syncope is the common cause of syncope in children, and its treatment has not yet been found satisfactory. Midodrine treatment was found to be effective and safe in paediatric patients with recurrent vasovagal syncope. However, further research is needed to determine the most effective treatment for this condition.
- Open Access
- 24 October 2023
- Published by Hatay Mustafa Kemal University Faculty of Medicine in Interdisciplinary Medical Journal
- Vol. 14 (50) , 214-218
Modified Konno Procedure for left ventricular outflow tract obstruction: report of two cases
Left ventricular outflow tract obstruction with a systolic anterior motion of the mitral valve is a challenging pathology. An intervention, either surgically or with a percutaneous technique is taken into consideration when the pressure gradient reaches critical levels. Subaortic myectomy is still the gold standard treatment modality in these particular patients. Modified Konno procedure may be added to the procedure when a significant gradient persists following subaortic resection, because of its association with increased outflow tract obstruction relief. We herein present our experiences with two cases that underwent modified Konno procedures for the treatment of hypertrophic obstructive cardiomyopathy.
- 24 October 2023
- Published by Hatay Mustafa Kemal University Faculty of Medicine in Interdisciplinary Medical Journal
- Vol. 14 (50) , 214-218
Open AccessModified Konno Procedure for left ventricular outflow tract obstruction: report of two cases
Left ventricular outflow tract obstruction with a systolic anterior motion of the mitral valve is a challenging pathology. An intervention, either surgically or with a percutaneous technique is taken into consideration when the pressure gradient reaches critical levels. Subaortic myectomy is still the gold standard treatment modality in these particular patients. Modified Konno procedure may be added to the procedure when a significant gradient persists following subaortic resection, because of its association with increased outflow tract obstruction relief. We herein present our experiences with two cases that underwent modified Konno procedures for the treatment of hypertrophic obstructive cardiomyopathy.
- Open Access
- 1 May 2023
- Published by SelSistem in Journal of Surgery and Medicine
- Vol. 7 (5) , 00
Truncus arteriosus with meandering pulmonary arteries
Truncus arteriosus is a rare, cyanotic, and congenital heart defect occurring due to failure in the differentiation of the aorta and the pulmonary artery during fetal development. The disease is categorized into four sub-categories in the Van Praagh and Collett & Edwards classification systems according to the origin of the pulmonary arteries. Surgical correction of the pulmonary arteries and repair of the ventricular septal defect is the preferred treatment strategy of choice; this intervention is required early in life. Here, we report a four-month-old baby with truncus arteriosus consisting of atypical pulmonary anatomy undefined by either the Van Praagh or the Collett & Edwards classification systems who underwent successful corrective surgery.
- 1 May 2023
- Published by SelSistem in Journal of Surgery and Medicine
- Vol. 7 (5) , 00
Open AccessTruncus arteriosus with meandering pulmonary arteries
Truncus arteriosus is a rare, cyanotic, and congenital heart defect occurring due to failure in the differentiation of the aorta and the pulmonary artery during fetal development. The disease is categorized into four sub-categories in the Van Praagh and Collett & Edwards classification systems according to the origin of the pulmonary arteries. Surgical correction of the pulmonary arteries and repair of the ventricular septal defect is the preferred treatment strategy of choice; this intervention is required early in life. Here, we report a four-month-old baby with truncus arteriosus consisting of atypical pulmonary anatomy undefined by either the Van Praagh or the Collett & Edwards classification systems who underwent successful corrective surgery.
- Open Access
- 1 January 2023
- Published by Sociedade Brasileira de Cirurgia Cardiovascular in Brazilian Journal of Cardiovascular Surgery
- Vol. 38 (4) , e20220268
Ascending Aortic Coarctation — an Atypical Location in a Non-Takayasu Arteritis Female Patient
Coarctation of the aorta is a well-known congenital cardiovascular disorder that typically occurs within proximity to the ductus arteriosus. The ascending aorta, distal descending aorta, and abdominal aorta are segments which are prone to development of an atypical coarctation. The etiologies of atypical cases are usually associated with various types of vasculitis syndromes or underlying genetic disorders. In this report, we present a 24-year-old female patient with an ascending aortic coarctation which developed secondary to an atherosclerotic process.
- 1 January 2023
- Published by Sociedade Brasileira de Cirurgia Cardiovascular in Brazilian Journal of Cardiovascular Surgery
- Vol. 38 (4) , e20220268
Open AccessAscending Aortic Coarctation — an Atypical Location in a Non-Takayasu Arteritis Female Patient
Coarctation of the aorta is a well-known congenital cardiovascular disorder that typically occurs within proximity to the ductus arteriosus. The ascending aorta, distal descending aorta, and abdominal aorta are segments which are prone to development of an atypical coarctation. The etiologies of atypical cases are usually associated with various types of vasculitis syndromes or underlying genetic disorders. In this report, we present a 24-year-old female patient with an ascending aortic coarctation which developed secondary to an atherosclerotic process.